Opportunity Information: Apply for PAR 14 070
Apply for PAR 14 070
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIA Limited Competition Renewal of, and Revisions to, the Alzheimers Disease Genetics Consortium (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866 Aging Research.
- This funding opportunity was created on Jan 14, 2014 and posted on Jan 14, 2014.
- Applicants must submit their applications by May 7, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
PAR-14-070 is a National Institutes of Health (NIH) funding opportunity announcement from the National Institute on Aging (NIA) that supports a very specific, limited-competition continuation of an existing research effort: the Alzheimers Disease Genetics Consortium. The opportunity is designed for the established NIA Alzheimers Disease Genetics Consortium to apply for either a renewal (continued support for the next project period) and/or a revision (a request to change or expand the scope, aims, or budget of an active award) focused on the genetics of Alzheimers disease. In practical terms, this is not an open call for new, unrelated applicants to form a new consortium; it is intended to maintain momentum and build on prior consortium infrastructure, data resources, and collaborative workflows that NIA has already invested in.
The award mechanism is a U01, which is an NIH cooperative agreement. That detail matters because a cooperative agreement typically means there is substantial scientific or programmatic involvement from NIH staff compared with a standard research project grant. The consortium structure and the cooperative agreement format are generally used when a program depends on coordinated multi-site work, common standards, shared resources, and collective decision-making, all of which are typical for large-scale genetics efforts. The scientific focus is the genetics of Alzheimers disease, which generally encompasses discovery and validation of genetic risk factors, large-scale analyses of genomic data, harmonization of phenotypes and cohorts, and activities that improve the field's ability to identify genetic contributors to disease risk, progression, or related traits.
Administratively, this opportunity sits in the NIH "Health" activity area and is listed under CFDA 93.866 (Aging Research). It is categorized as a discretionary funding opportunity and explicitly states that there is no cost sharing or matching requirement, meaning applicants are not required to contribute non-federal funds as a condition of the award. The funding announcement was posted and created on January 14, 2014. The original and current closing date is listed as May 7, 2017, and the announcement was archived on June 7, 2017, which signals that the solicitation is no longer active for new submissions after that period.
Eligibility is limited and includes an important restriction on foreign involvement. While the eligibility field is summarized as "Others (see text field entitled Additional Information on Eligibility for clarification)," the included eligibility language makes the constraints clear: non-U.S. entities (foreign institutions) are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components as defined in the NIH Grants Policy Statement are not allowed. In other words, this is intended to be carried out entirely through eligible U.S.-based applicant organizations without foreign institutional participation as formal components of the project.
For applicants or readers seeking the full official announcement text, the opportunity points to the NIH Grants Guide page at http://grants.nih.gov/grants/guide/pa-files/PAR-14-070.html. The contact information provided is primarily technical support through the NIH Office of Extramural Research (OER) webmaster for access or linking issues, rather than a scientific program contact, indicating the summary provided here is more of a top-level listing than a full program narrative. Overall, the main takeaway is that PAR-14-070 was a time-limited, NIA-sponsored, limited-competition cooperative agreement opportunity intended to continue and/or expand the work of the existing Alzheimers Disease Genetics Consortium through renewal and revision applications focused on Alzheimers genetics, under NIH's aging research portfolio.
FAQs: NIH NIA PAR-14-070 (Alzheimers Disease Genetics Consortium - Limited Competition)
What is PAR-14-070?
PAR-14-070 is a National Institutes of Health (NIH) funding opportunity announcement from the National Institute on Aging (NIA) focused on Alzheimer disease genetics. It supports a very specific, limited-competition continuation of an existing effort: the NIA Alzheimer’s Disease Genetics Consortium.
Is this funding opportunity open to new applicants who want to start a new consortium?
No. Based on the description provided, this is not an open call for new, unrelated applicants to form a new consortium. It is intended for the established NIA Alzheimer’s Disease Genetics Consortium to continue building on previously funded infrastructure, data resources, and collaborative workflows.
What types of applications are supported under this opportunity?
The opportunity is designed to support either (1) a renewal application (continued support for the next project period) and/or (2) a revision application (a request to change or expand the scope, aims, or budget of an active award), specifically in the area of Alzheimer’s disease genetics.
What is the award mechanism for PAR-14-070?
The award mechanism is a U01, which is an NIH cooperative agreement. This matters because cooperative agreements typically involve substantial scientific or programmatic involvement from NIH staff compared with standard research project grants.
What does a U01 cooperative agreement imply for how the project is run?
A U01 cooperative agreement format is generally used when the work depends on coordinated multi-site efforts, common standards, shared resources, and collective decision-making. The description indicates this aligns with the consortium structure and large-scale genetics work being supported.
What scientific area does this opportunity focus on?
The scientific focus is the genetics of Alzheimer’s disease. The description notes that this generally includes discovery and validation of genetic risk factors, large-scale analyses of genomic data, harmonization of phenotypes and cohorts, and activities that improve the field’s ability to identify genetic contributors to disease risk, progression, or related traits.
Which NIH institute sponsors this opportunity?
This funding opportunity announcement is from the National Institute on Aging (NIA), part of NIH.
What is the activity area and CFDA listing associated with this opportunity?
It is listed under the NIH “Health†activity area and under CFDA 93.866 (Aging Research).
Is PAR-14-070 a discretionary funding opportunity?
Yes. The description categorizes it as a discretionary funding opportunity.
Is cost sharing or matching required?
No. The opportunity explicitly states there is no cost sharing or matching requirement, meaning applicants are not required to contribute non-federal funds as a condition of the award.
Are foreign (non-U.S.) institutions eligible to apply?
No. The eligibility language provided states that non-U.S. entities (foreign institutions) are not eligible to apply.
Can a U.S. organization apply if it has a non-U.S. component?
No. The eligibility restrictions provided state that non-U.S. components of U.S. organizations are not eligible.
Are foreign components allowed in any form on this project?
No. The information provided states that foreign components (as defined in the NIH Grants Policy Statement) are not allowed, indicating the project is intended to be carried out entirely through eligible U.S.-based applicant organizations without foreign institutional participation as formal project components.
When was this funding opportunity posted?
The funding announcement was posted (and created) on January 14, 2014.
What was the closing date for applications?
The original and current closing date is listed as May 7, 2017.
Is this opportunity still active?
No. The announcement was archived on June 7, 2017, which indicates it is no longer active for new submissions after that period.
Where can applicants find the full official announcement text?
The opportunity points to the NIH Grants Guide page: http://grants.nih.gov/grants/guide/pa-files/PAR-14-070.html.
Who is listed as the contact for this opportunity?
The contact information provided is primarily for technical support through the NIH Office of Extramural Research (OER) webmaster, focused on access or linking issues, rather than a scientific program contact.
What is the main purpose of PAR-14-070 in practical terms?
In practical terms, it is intended to maintain momentum and build on prior consortium infrastructure, data resources, and collaborative workflows that NIA has already invested in, through renewal and/or revision applications tied to the existing Alzheimer’s Disease Genetics Consortium.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Defense Production Act (DPA) Title III Solid Rocket Mortors Project
Previous opportunity: National Fish Habitat Action Plan
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 14 070
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 14 070) also looked into and applied for these:
| Funding Opportunity |
|---|
| HIV Early Intervention Services (EIS Program) Existing Geographic Service Areas (EISEGA) Apply for HRSA 14 117 Funding Number: HRSA 14 117 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Resource and Technical Assistance Center for HIV Prevention and Care for Black Men who Have Sex with Men (Black MSM) Cooperative Agreement Apply for HRSA 14 106 Funding Number: HRSA 14 106 Agency: Health Resources and Services Administration Category: Health Funding Amount: $1,500,000 |
| Shared Instrumentation Grant Program (S10) Apply for PAR 14 073 Funding Number: PAR 14 073 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition to Develop a BrainSpan RNA seq Browser (R24) Apply for RFA MH 15 100 Funding Number: RFA MH 15 100 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alzheimers Disease Research Centers (P50) Apply for RFA AG 15 002 Funding Number: RFA AG 15 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Alzheimers Disease Core Centers (P30) Apply for RFA AG 15 001 Funding Number: RFA AG 15 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Poison Center Support and Enhancement Apply for HRSA 14 016 Funding Number: HRSA 14 016 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Supporting Healthy Start Performance Project Apply for HRSA 14 042 Funding Number: HRSA 14 042 Agency: Health Resources and Services Administration Category: Health Funding Amount: $2,000,000 |
| Service Area Competition Additional Area (SAC AA) DC, FL, GA, ID, IL, KS, MO, MT, NY, OR, PA Apply for HRSA 14 116 Funding Number: HRSA 14 116 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening National Capacity in Malaria and Other Infectious Disease Operations Research Apply for RFA GH 14 003 Funding Number: RFA GH 14 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,250,000 |
| Reimbursement of Travel and Subsistence Expenses for Living Organ Donation Apply for HRSA 14 015 Funding Number: HRSA 14 015 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| A Creutzfeldt Jakob Disease (CJD) Lookback Study Assessing the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt Jakob Disease Apply for RFA CK 14 005 Funding Number: RFA CK 14 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $76,000 |
| NIH Directors Biomedical Research Workforce Innovation Award Broadening Experiences in Scientific Training (BEST) (DP7) Apply for RFA RM 13 019 Funding Number: RFA RM 13 019 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Community Health Projects Related to Contamination at Brownfield/Land Reuse Sites (ATSDR CHPs) Apply for CDC RFA TS14 1404 Funding Number: CDC RFA TS14 1404 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
| Secretarys Minority AIDS Initiative Funding to Increase HIV Prevention and Care Service Delivery among Health Centers Serving High HIV Prevalence Jurisdictions Apply for CDC RFA PS14 1410 Funding Number: CDC RFA PS14 1410 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $850,000 |
| Kyrgyzstan TB Program Apply for RFA 176 14 000005 Funding Number: RFA 176 14 000005 Agency: Kazakhstan USAID Almaty Category: Health Funding Amount: $12,800,000 |
| Well Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) Program Apply for CDC RFA DP13 130202CONT14 Funding Number: CDC RFA DP13 130202CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Notification of Request for comments on potential RFA for implementation of the Integrated Family Health Program (IFHP) II in Ethiopia Apply for RFA 663 14 000002 Funding Number: RFA 663 14 000002 Agency: Ethiopia USAID Addis Ababa Category: Health Funding Amount: $75,000,000 |
| Research Centers for Pharmacogenomics in Precision Medicine (P50) Apply for PAR 14 075 Funding Number: PAR 14 075 Agency: National Institutes of Health Category: Health Funding Amount: $1,750,000 |
| Beyond HAART Innovative Approaches to Cure HIV 1 (U19) Apply for RFA AI 14 004 Funding Number: RFA AI 14 004 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 14 070", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.